Pierre Socha is a Partner at Amadeus Capital Partners since 2012, focusing on investments in transformative technologies across various sectors including healthtech, quantum, and cybersecurity, with over $1 billion under management and more than 200 investments. In addition to this role, Pierre serves on the boards of several innovative companies, such as Constructive Bio, Ori Biotech, and V7, contributing expertise in synthetic reprogramming, gene therapies, and AI-driven computer vision. Other board memberships include Quibim, Inotec AMD, PhoreMost Ltd, and Doctify, highlighting a strong emphasis on advancing medical technologies. Pierre also holds a position on the Strategic Advisory Council of The Research and Development Society starting in 2025. Academic credentials encompass executive programs at prestigious institutions, such as the Massachusetts Institute of Technology and Harvard Business School, alongside advanced degrees in Environmental Economics and Finance.
This person is not in the org chart
This person is not in any teams
This person is not in any offices